An apparatus for regulating the concentration of glucose in the blood of a person includes: at least one glucose sensor that is arranged to measure the glucose concentration of the person, for example in the interstitial fluid or blood; a pump for selectively introducing at least one substance influencing the blood glucose levels into the body of the person, for instance by at least one cannula or catheter to be inserted into the body of said person, and a control for controlling said at least one substance influencing the blood glucose levels to be introduced to the person based on data received from said glucose sensor. Said apparatus includes at least one further sensor that is arranged to monitor a further characteristic of the person. The at least one further sensor may include an accelerometer, a heart rate sensor, a temperature sensor, a pH sensor, a ketone sensor, a GPS receiver, and/or a skin resistance sensor.

A system and method for assessing an intravenous catheter site is described in embodiments herein. An application accessible on a mobile device may be used to take calibrated photographs of an intravenous catheter site. The resulting calibrated image may be compared to previously taken calibrated images to determine a complication. Success of treatments to the complication may be tracked and the patient's electronic medical record may be updated.

Disclosed are processes and techniques implementable by devices and a drug delivery system to maintain optimal drug delivery for a user according to a user's diabetes treatment plan. The disclosed techniques enable a drug delivery device that received an analyte measurement value from an analyte sensor during a prior cycle time to determine a present analyte measurement value has not been received during a present cycle time. A processor of the drug delivery device may, in response to the determination, initiate an action to obtain the present analyte measure value from another device or an estimate of the present analyte measurement value. Based on an outcome of the initiated action, the processor may calculate a dosage of the drug using the present analyte measurement value or information related to the present analyte measurement value. The drug delivery device may also be operable to output the calculated dosage of the drug.

There is provided a method comprising: computing a target nutritional goal to reach at an end of a time interval based on a real time energy expenditure of a patient, wherein the target nutritional goal comprises a volume to be delivered (VTBD) by the end of the time interval corresponding to a target amount of energy expenditure of the patient over the time interval, computing a target feeding profile defining a target feeding rate for enteral feeding of the patient for reaching the VTBD by the end of the time interval, continuously monitoring the real time energy expenditure, adapting the target nutritional goal and corresponding VTBD to compute a maximum VTBD to reach at the end of the time interval according to the monitoring, and dynamically adapting the target feeding rate and the corresponding target feeding profile for a remaining portion of the time interval for reaching the maximum VTBD.

A medical wetness sensing device includes a cover, a first and second electrically conductive portions housed in the cover, an electrically insulative portion housed in the cover, and a compressible portion. The cover defines an outer surface. The first and second electrically conductive portions are exposed along an inner surface of the device. The first and second electrically conductive portions are configured to transmit a test signal indicating an absence or presence of a liquid on the inner surface. The electrically insulative portion electrically isolates the first electrically conductive portion from the second electrically conductive portion. The compressible portion is flexible, compressible, and configured such that the inner surface of the device is conformable to skin of a wearer of the device. The compressible portion is formed by at least one of the cover, the first and second electrically conductive portions, and the electrically insulative portion.

A drug delivery system having a drug delivery device and an associated sensor is provided. The sensor can be associated with a sensing site on user. The drug delivery device can be positioned over the sensor in any rotational position and can be associated with an infusion site on the user. The close positioning of the sensor and the drug delivery device allows data from the sensor to be relayed to the drug delivery device and then on to a remote control device. Further, the drug delivery device can be replaced at the end of its duration of use, which is shorter than the duration of use of the sensor, without disturbing the sensor. Subsequent drug delivery devices can then be used with the sensor while allowing each corresponding infusion site to be changed, thereby providing more efficient operation of the drug delivery system.

There is provided a method comprising: computing a target nutritional goal to reach at an end of a time interval based on a real time energy expenditure of a patient, wherein the target nutritional goal comprises a volume to be delivered (VTBD) by the end of the time interval corresponding to a target amount of energy expenditure of the patient over the time interval, computing a target feeding profile defining a target feeding rate for enteral feeding of the patient for reaching the VTBD by the end of the time interval, continuously monitoring the real time energy expenditure, adapting the target nutritional goal and corresponding VTBD to compute a maximum VTBD to reach at the end of the time interval according to the monitoring, and dynamically adapting the target feeding rate and the corresponding target feeding profile for a remaining portion of the time interval for reaching the maximum VTBD.

A method may include obtaining, with a first temperature sensor, a first temperature measurement at a first location on a body of a patient adjacent a catheter insertion site of a catheter; obtaining, with an array of temperature sensors, a plurality of temperature measurements at a plurality of locations on the body of the patient, each of the plurality of locations being spaced apart from the first location, and the plurality of locations including locations at a plurality of different distances from the first location; determining, with at least one processor, based on the first temperature measurement and the plurality of temperature measurements, an alert condition associated with a dressing and/or securement device and/or the catheter; and in response to determining the alert condition, generating, with at least one processor, an alert to a user.

As an IV infiltration occurs and fluid leaks into surrounding tissues, several physiological changes are expected locally. The systems and methods described herein provide a scalable automated IV infiltration detection device to provide medical staff an early warning of a possible infiltration such that they can respond accordingly. The systems and methods capture the physiological state of the user at or around a peripheral catheter insertion site by incorporating one or more modalities of wearable sensing, processing the data collected from these wearable sensors, detecting the presence of extravascular fluid, and providing an indication to a medical professional.

An insulin delivery supervisor (IDS) with a safety analysis and supervision function that can reside between the insulin request and the insulin delivery and can intercept any excessive insulin requests before the insulin was delivered. The IDS can be implemented in any system based on insulin pump or pen and will work with either SMBG or CGM modes of blood glucose monitoring.